|
13 Companies |
|
19 Products |
|
19 Products |
|
22 Mechanisms of Action |
|
0 Trials |
|
57 News |
|
| «12 |
- Trial initiation date, Surgery: Robotic-Assisted Surgery in Treating Patients With Spine Tumors (clinicaltrials.gov) - May 31, 2012
P=N/A, N=0, Withdrawn, Sponsor: City of Hope Medical Center
Initiation date: May 2012 --> Dec 2012
- Enrollment open, Surgery: Minimally Invasive Surgery in Treating Patients With Spinal Tumors (clinicaltrials.gov) - May 29, 2012
P=N/A, N=30, Recruiting, Sponsor: City of Hope Medical Center
Initiation date: May 2012 --> Dec 2012 Not yet recruiting --> Recruiting
- emvododstat (PTC299) / PTC Therap
Trial suspension: PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors (clinicaltrials.gov) - Apr 16, 2012
P1, N=30, Suspended, Sponsor: Pediatric Brain Tumor Consortium
Not yet recruiting --> Recruiting Recruiting --> Suspended
- New P2 trial: Proton Radiation Therapy for Spinal Tumors (clinicaltrials.gov) - Mar 28, 2012
P2, N=34, Recruiting, Sponsor: University of Florida
- Trial termination: MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer (clinicaltrials.gov) - Mar 1, 2012
P1, N=33, Terminated, Sponsor: Pediatric Brain Tumor Consortium
Recruiting --> Suspended Active, not recruiting --> Terminated; This Phase I study was permanently closed to patient accrual on February 23, 2011, due to the discontinuation of support from MERCK.
- Enrollment change: Stereotactic Body Radiation Therapy (SBRT) for Tumors Near the Spinal Cord (clinicaltrials.gov) - Jan 31, 2012
P=N/A, N=21, Completed, Sponsor: University of Florida
Active, not recruiting --> Terminated; This Phase I study was permanently closed to patient accrual on February 23, 2011, due to the discontinuation of support from MERCK. N=32 --> 21
- topotecan / Generic mfg., carboplatin / Generic mfg., tamoxifen / Generic mfg.
Trial completion, Metastases: Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors (clinicaltrials.gov) - Sep 19, 2011
P2, N=50, Completed, Sponsor: City of Hope Medical Center
N=32 --> 21 Active, not recruiting --> Completed